Back to search

Boston University

Availability, price and consumption patterns of medicines for non-communicable diseases in Kenya

Abstract

dc:description.abstract

BACKGROUND: The Comprehensive Global Monitoring Framework on non-communicable diseases (NCDs) identifies availability and price of NCD medicines as critical indicators of access to treatment. This dissertation project conducted in eight counties in Kenya studies the: i) availability and prices of NCD medicines in public and non-profit health facilities and private drug outlets; ii) feasibility and validity of data collection on medicine availability and price through telephone interviews compared to in-person; and iii) effects Novartis Access, a NCD medicine pricing scheme, on medicine consumption patterns. METHODS: In 2016 medicine availability and price data were collected in-person through household and facility surveys. Between 2016 and 2018, monthly telephone surveillance data on medicines from health facilities and households were compared with data collected in-person. In-depth interviews (IDIs) were conducted with 25 respondents and data collectors to understand their perceptions on both modes of data collection. Sales data on Novartis Access medicines and their generic and therapeutic equivalents were collected from a major wholesaler. The effects of Novartis Access medicines on the consumption generic and therapeutic equivalents and on the consumption of medicines not listed in the national Essential Medicines List (EML) were estimated using segmented regression analysis. RESULTS AND DISCUSSION: Availability of NCD medicines was low, especially among primary care facilities in the public sector. Prices varied substantially by provider type and level of care, with prices generally lower in the public sector. Telephone interviews were cheaper than in-person interviews; demonstrated high response rates; showed statistically significant level of agreement and correlation with medicine availability and price data respectively from in-person interviews. Most IDI participants mentioned phone interviews were more convenient and yielded good data. Consumption of non-EML medicines was widespread. The introduction of Novartis Access had no statistically significant effect on the overall level and trend of consumption of generic equivalents and non-EML medicines. CONCLUSION: Interventions need to be implemented to address the poor availability of NCD medicines and large variation in prices and to ensure that access initiatives focus on priority medicines. Phone interviews are reliable and valid for collecting data on medicine availability and prices and should be routinely employed.

Degree

thesis:*
Name thesis:degree_name
Doctor of Public Health
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Public Health
Grantor
Boston University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ashigbie, Paul Gamelie Kwame
Advisor dc:contributor.advisor
  • Wirtz, Veronika J.

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/34815

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Ashigbie, Paul Gamelie Kwame. Availability, price and consumption patterns of medicines for non-communicable diseases in Kenya. doctoral thesis, Boston University, 2019. https://hdl.handle.net/2144/34815